Blog

Nazik Hammad: Join our session ASCO2024 to discuss proposed gender competency framework for cancer workforce

Nazik Hammad/X

May 14, 2024, 10:44

Nazik Hammad: Join our session ASCO2024 to discuss proposed gender competency framework for cancer workforce

Nazik Hammad shared a post by Julie Gralow on X/Twitter, adding:

”Please join our session ASCO2024. We will also discuss proposed gender competency framework for cancer workforce to provide competent respectful care for women encompassing both biomedical and structural competencies.”

Quoting Julie Gralow’s post:

”Don’t miss this session at ASCO2024 – North American launch of The Lancet Commission in Women, Power, and Cancer.”

Source: Nazik Hammad/X and Julie Gralow/X

Nazik Hammad is a Sudanese Canadian Professor of medical oncology, at Saint Michael Hospital, Department of Medicine, University of Toronto . Her academic work and research interests include medical education and workforce development in low and middle-income countries (LMIC) particularly in sub-Saharan Africa. Other research and academic interests include value-based cancer care, global and local inequities and disparities in cancer, global health and global oncology, women as health care professionals and cancer in conflict zones. Together with colleagues in Africa she led the first Choosing Wisely Africa initiative. She is a co-author in the Lancet Oncology commission for Cancer in Sub-Saharan Africa and is a commissioner in the Lancet Commission on Women, Power and Cancer.

Nazik Hammad is a Professor at the Division of Hematology and Oncology, St. Michael’s Hospital, University of Toronto. She is the Chair of the Education and Training Committee of the African Organization for Research and Training in Cancer (AORTIC). Dr. Hammad is a visiting professor at the University of Nairobi, Kenya. She is the co-chair of the Network for Advancing Black Learners (Medical Students and Residents) in Ontario. She is the former Director of Global Health at the Faculty of Health Sciences at Queen’s University. Dr. Hammad is the recipient 2019 Harvard Global Health Catalyst Distinguished Young Leader Award.

Julie Gralow is the Chief Medical Officer (CMO) and Executive Vice President of the American Society of Clinical Oncology (ASCO). Previously, she was the Jill Bennett Endowed Professor of Breast Cancer at the University of Washington School of Medicine, Professor in the Clinical Research Division of the Fred Hutchinson Cancer Research Center, as well as Director of Breast Medical Oncology at the Seattle Cancer Care Alliance. She is the founder of the Women’s Empowerment Cancer Advocacy Network (WE CAN). Dr. Gralow received the ASCO Humanitarian Award in 2018 for her work in empowering women cancer patients and survivors globally.